sf2000sd
Small moleculeexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2016 (NCT02941159)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
HIVEP1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- sf2000sd
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02941159 | Phase 1 | Sep 1, 2016 | Copperbelt University of Zambia, Dr Ludwick Sondashi Formular Clinic, National AIDS/TB/STIs Council of Zambia, Tropical Diseases Research Centre, Zambia, University of Zambia |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Copperbelt University of Zambia | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Dr Ludwick Sondashi Formular Clinic | Academic/Hospital | 1 | 0 | 1 | 2016 |
| National AIDS/TB/STIs Council of Zambia | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Tropical Diseases Research Centre, Zambia | Academic/Hospital | 1 | 1 | 1 | 2016 |
| University of Zambia | Academic/Hospital | 1 | 0 | 1 | 2016 |
5 organizations
Page 1 / 1